Cancer Therapies Directory Resources

Submit URL Cancer Therapies

Cancer Therapies News

BiPar Sciences to Present At the 31st CTRC-AACR Annual San Antonio Breast Cancer Symposium (GlobeNewswire via Yahoo! Finance)

BRISBANE, Calif., Dec. 4, 2008 -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing PARP inhibitors as novel cancer therapies, announced today that the company's lead PARP product candidate for triple negative breast cancer, BSI-201, will be the subject of a poster presentation at the 2008 annual San Antonio Breast Cancer Symposium .

Gene Packaging Tells Story Of Cancer Development (Medical News Today)

To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging. Specifically, their findings in the December 2, 2008, issue of PLoS Biology point to the three dimensional chromatin packaging around genes formed by tight, rosette-like loops of Polycomb group proteins (PcG).

Cell Genesys, Takeda terminate pact on GVAX immunotherapy for prostate cancer (PharmaBiz)

Cell Genesys, Inc and Takeda Pharmaceutical Company Limited, together with its wholly-owned subsidiary Millennium: The Takeda Oncology Company, announced that they have mutually agreed to suspend the further development of GVAX immunotherapy for prostate cancer and that Takeda has ended the collaboration agreement with Cell Genesys for the development and commercialization of the product.

Epitherapeutics Receives Funding from Novo and SEED Capital Denmark for Cancer Drug Development in the Field of ... (Centre Daily Times)

Epitherapeutics Aps announced today the receipt of funding from two of the leading Danish life science investor groups, Novo A/S and SEED Capital Denmark to advance the discovery and development of new cancer treatments by leveraging breakthroughs in the field of Epigenetics.

Gene packaging tells story of cancer development (EurekAlert!)

( Johns Hopkins Medical Institutions ) To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging.